$SLDB
Solid Biosciences Inc.

2021 Q2 Form 10-Q Financial Statement

#000156459021044656 Filed on August 16, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2 2020 Q1
Revenue $3.594M $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.766M $5.530M $5.250M
YoY Change 22.35% 3.17% -25.32%
% of Gross Profit
Research & Development $15.51M $13.45M $19.67M
YoY Change 15.34% -37.76% -15.47%
% of Gross Profit
Depreciation & Amortization $718.0K $1.334M $1.026M
YoY Change -46.18% 102.74% 72.15%
% of Gross Profit
Operating Expenses $22.28M $18.97M $26.86M
YoY Change 17.44% -29.66% -11.36%
Operating Profit -$18.69M
YoY Change
Interest Expense -$13.00K -$13.00K $164.0K
YoY Change 0.0% -103.51% -67.84%
% of Operating Profit
Other Income/Expense, Net -$10.00K $0.00 $165.0K
YoY Change -100.0% -77.08%
Pretax Income -$18.70M -$18.99M -$26.69M
YoY Change -1.55% -28.42% -9.77%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$18.70M -$18.99M -$26.69M
YoY Change -1.54% -28.42% -9.76%
Net Earnings / Revenue -520.17%
Basic Earnings Per Share -$0.17
Diluted Earnings Per Share -$0.17 -$394.3K -$555.3K
COMMON SHARES
Basic Shares Outstanding 112.3M 46.07M
Diluted Shares Outstanding 112.3M

Balance Sheet

Concept 2021 Q2 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $249.0M $40.40M $53.60M
YoY Change 516.24% -40.05% -43.4%
Cash & Equivalents $200.6M $40.44M $53.51M
Short-Term Investments $48.35M $0.00 $400.0K
Other Short-Term Assets $5.833M $3.100M $4.300M
YoY Change 88.16% -71.56% -38.57%
Inventory
Prepaid Expenses
Receivables $286.0K
Other Receivables $0.00
Total Short-Term Assets $255.1M $43.50M $57.90M
YoY Change 486.39% -44.46% -43.12%
LONG-TERM ASSETS
Property, Plant & Equipment $7.128M $9.582M $15.50M
YoY Change -25.61% -19.0% 29.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.070M $500.0K $500.0K
YoY Change 314.0% 139.23% 139.23%
Total Long-Term Assets $10.78M $14.50M $16.10M
YoY Change -25.66% -19.37% -12.56%
TOTAL ASSETS
Total Short-Term Assets $255.1M $43.50M $57.90M
Total Long-Term Assets $10.78M $14.50M $16.10M
Total Assets $265.9M $58.00M $74.00M
YoY Change 358.37% -39.77% -38.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.003M $2.800M $2.400M
YoY Change 7.25% -50.0% -55.56%
Accrued Expenses $7.714M $8.315M $10.30M
YoY Change -7.23% 38.42% 18.39%
Deferred Revenue $10.05M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $220.0K $200.0K $200.0K
YoY Change 10.0% 0.0% 0.0%
Total Short-Term Liabilities $22.55M $13.20M $12.90M
YoY Change 70.8% -3.45% -11.47%
LONG-TERM LIABILITIES
Long-Term Debt $412.0K $600.0K $700.0K
YoY Change -31.33% -25.0% -12.5%
Other Long-Term Liabilities $4.962M $3.500M $3.900M
YoY Change 41.77% -33.96% -31.58%
Total Long-Term Liabilities $5.374M $4.100M $4.600M
YoY Change 31.07% -32.79% -29.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $22.55M $13.20M $12.90M
Total Long-Term Liabilities $5.374M $4.100M $4.600M
Total Liabilities $27.92M $17.30M $17.50M
YoY Change 61.38% -12.67% -17.06%
SHAREHOLDERS EQUITY
Retained Earnings -$440.2M -$362.0M
YoY Change 21.61% 41.85%
Common Stock $678.1M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $237.9M $40.71M $56.46M
YoY Change
Total Liabilities & Shareholders Equity $265.9M $58.00M $74.00M
YoY Change 358.37% -39.77% -38.45%

Cashflow Statement

Concept 2021 Q2 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income -$18.70M -$18.99M -$26.69M
YoY Change -1.54% -28.42% -9.76%
Depreciation, Depletion And Amortization $718.0K $1.334M $1.026M
YoY Change -46.18% 102.74% 72.15%
Cash From Operating Activities -$17.10M -$13.07M -$29.27M
YoY Change 30.8% -50.3% 12.91%
INVESTING ACTIVITIES
Capital Expenditures -$344.0K -$80.00K $681.0K
YoY Change 330.0% -92.98% -65.13%
Acquisitions
YoY Change
Other Investing Activities -$48.37M $400.0K $7.100M
YoY Change -12192.0% -98.42% -258.13%
Cash From Investing Activities -$48.71M $320.0K $6.418M
YoY Change -15322.5% -98.67% -199.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -234.0K 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -17.10M -13.07M -29.27M
Cash From Investing Activities -48.71M 320.0K 6.418M
Cash From Financing Activities -234.0K 0.000 0.000
Net Change In Cash -66.04M -12.75M -22.86M
YoY Change 417.98% 493.02% -29.4%
FREE CASH FLOW
Cash From Operating Activities -$17.10M -$13.07M -$29.27M
Capital Expenditures -$344.0K -$80.00K $681.0K
Free Cash Flow -$16.75M -$12.99M -$29.96M
YoY Change 28.96% -48.37% 7.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
90000
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
40713000
CY2021Q2 us-gaap Liabilities
Liabilities
27919000
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-13000
CY2020Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-13000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-27000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
151000
CY2021Q2 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
286000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
158901000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8153000
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
110295992
CY2021Q2 sldb Pre Funded Warrants Outstanding
PreFundedWarrantsOutstanding
2158329
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
112000
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10048000
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10359000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2419000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
525000
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
4306000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
10359000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1300000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-440164000
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
110295992
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
237938000
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
678001000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11000
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
6929000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
265857000
CY2021Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
3594000
us-gaap Operating Income Loss
OperatingIncomeLoss
-45833000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
0
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18695000
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
112298982
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
48163094
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
100850878
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.39
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5928270
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-18987000
us-gaap Profit Loss
ProfitLoss
-35595000
us-gaap Profit Loss
ProfitLoss
-45681000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-11000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-18986000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-35606000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
253000000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3635000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-18695000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-11000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
237938000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
132086000
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
8872000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
134878000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
38000
us-gaap Net Income Loss
NetIncomeLoss
-35595000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-11000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
237938000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
56456000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3243000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-18987000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
80048000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6347000
us-gaap Net Income Loss
NetIncomeLoss
-45681000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
40713000
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
286000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3892000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1818000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-6364000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-42342000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38466000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
6740000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
401000
CY2020Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
384000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
759000
us-gaap Payments For Proceeds From Availableforsale Securities Shortterm
PaymentsForProceedsFromAvailableforsaleSecuritiesShortterm
-7900000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
134878000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
38000
sldb Change In Unrealized Loss
ChangeInUnrealizedLoss
-11000
sldb Increase Decrease In Right Of Use Asset Due To Lease Termination
IncreaseDecreaseInRightOfUseAssetDueToLeaseTermination
-1233000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
47000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
27000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-440164000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-18695000
us-gaap Profit Loss
ProfitLoss
-35595000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38466000
CY2021Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
248959000
CY2021Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
90000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0
CY2021Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
155757000
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
48350000
CY2021Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
204107000
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
84462000
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
84462000
CY2020Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
200609000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
154744000
CY2021Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
90000
CY2021Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2070000
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
327000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
202769000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
155071000
CY2020Q4 us-gaap Exchange Fees
ExchangeFees
313000
CY2020Q4 sldb Common Stock Shares Issued Warrant To Purchase
CommonStockSharesIssuedWarrantToPurchase
30000
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.29
CY2020Q4 sldb Agreement Termination Period
AgreementTerminationPeriod
P60D
CY2020Q4 sldb Agreement Written Notice Period
AgreementWrittenNoticePeriod
P30D
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
48361000
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
11000
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
48350000
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis
48361000
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
48350000
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
48361000
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
48350000
sldb Available For Sale Securities Weighted Average Maturity Period
AvailableForSaleSecuritiesWeightedAverageMaturityPeriod
P0Y6M
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
0
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17284000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
16866000
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10156000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8713000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7128000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8153000
CY2021Q2 us-gaap Depreciation
Depreciation
718000
us-gaap Depreciation
Depreciation
1453000
CY2021Q2 sldb Prepaid Research And Development Expenses Current
PrepaidResearchAndDevelopmentExpensesCurrent
1953000
CY2020Q4 sldb Prepaid Research And Development Expenses Current
PrepaidResearchAndDevelopmentExpensesCurrent
2674000
CY2021Q2 sldb Prepaid Tenant Improvement Allowance Receivable
PrepaidTenantImprovementAllowanceReceivable
348000
CY2021Q2 sldb Prepaid Expense And Other Assets Miscellaneous Current
PrepaidExpenseAndOtherAssetsMiscellaneousCurrent
3442000
CY2020Q4 sldb Prepaid Expense And Other Assets Miscellaneous Current
PrepaidExpenseAndOtherAssetsMiscellaneousCurrent
1483000
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5743000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4157000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7714000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8640000
CY2019Q3 sldb Gross Proceeds From Issuance Of Private Placement
GrossProceedsFromIssuanceOfPrivatePlacement
59977000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
604400
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3001895
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3635000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3243000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6542000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6347000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18987000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-35595000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-45681000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
48111186
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.95
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5213219

Files In Submission

Name View Source Status
0001564590-21-044656-index-headers.html Edgar Link pending
0001564590-21-044656-index.html Edgar Link pending
0001564590-21-044656.txt Edgar Link pending
0001564590-21-044656-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sldb-10q_20210630.htm Edgar Link pending
sldb-10q_20210630_htm.xml Edgar Link completed
sldb-20210630.xsd Edgar Link pending
sldb-20210630_cal.xml Edgar Link unprocessable
sldb-20210630_def.xml Edgar Link unprocessable
sldb-20210630_lab.xml Edgar Link unprocessable
sldb-20210630_pre.xml Edgar Link unprocessable
sldb-ex101_33.htm Edgar Link pending
sldb-ex104_34.htm Edgar Link pending
sldb-ex311_6.htm Edgar Link pending
sldb-ex312_10.htm Edgar Link pending
sldb-ex321_8.htm Edgar Link pending
sldb-ex322_7.htm Edgar Link pending